Talaris Therapeutics is a late-clinical stage biotechnology company based in Boston, MA and Louisville, KY. Talaris is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe auto-immune and immune-mediated disorders.

Biotechnology

Talaris Therapeutics

Talaris Therapeutics' headquarters in Louisville, KY, United States

Yiming Huang

Dillon Fairchild

Hong Xu

Sapna Srivastava

Francois Nader

Geoff Mackay

Mark Mcdade

Gaurav Shah

Karen Smith

Leadership Team

Research and Development Team

Talaris Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Research and Development Team

Offices

Similar companies